Evaxion A/S logo

Evaxion A/S

0001828253

Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.

77
Trusted
Trust Score

Official Registry

Legal Name
Evaxion A/S
Organization Number
0001828253
VAT Number
000000000
Company Status
Active
Address
DR NEERGAARDS VEJ 5F, HOERSHOLM,
Industry Codes
Biological Products, (No Diagnostic Substances), 2836

Last verified: 1/2/2026

AI Quality Analysis

Industry
Biotechnology
SSL/HTTPS
Secure
Professional Email
No

Trust Score Breakdown

Registry Verified35/35
Quality Score42/60
News Sentiment0/5

Website Highlights

Last updated: 1/2/2026

🌟 Similar Trusted Businesses

vTv Therapeutics Inc.

vTv Therapeutics Inc. logo
89/100 · Highly Trusted

vTv Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of diabetes patients. They focus on developing oral, small molecule drug candidates. Their lead candidate is cadisegliatin, a potential adjunctive therapy to insulin for type 1 diabetes. They are also exploring indications for type 2 diabetes and other chronic conditions.

3980 PREMIER DR, USA
View Profile

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. logo
86/100 · Highly Trusted

Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company is developing novel immunotherapies using foreign patterns to trigger the innate immune system, which teaches the immune system to recognize and kill cancer. Bolt was founded in 2015.

900 CHESAPEAKE DRIVE, USA
View Profile

IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. logo
86/100 · Highly Trusted

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. They are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors.

825 INDUSTRIAL ROAD, USA
View Profile